OverviewSuggest Edit

Antidote is a digital health company on a mission to accelerate the breakthroughs of new treatments by bridging the gap between medical research and the people who need them. 
Antidote was launched as TrialReach in 2010 and rebranded to Antidote in 2016. We're based in the U.S. and London, U.K.
TypePrivate
Founded2009
HQLondon, GB
Websiteantidote.me
Employee Ratings4.5

Latest Updates

Employees (est.) (May 2020)55(+2%)
Revenue (FY, 2018)£1.5 M(-29%)

Key People/Management at Antidote

Laurent Schockmel

Laurent Schockmel

CEO
Pablo Graiver

Pablo Graiver

Founder
Keith Lovell

Keith Lovell

CFO
Joanna Anderson

Joanna Anderson

Founder
Kathy Freeman

Kathy Freeman

VP Business Development
Grace McElroy

Grace McElroy

VP Marketing & Partnerships
Show more

Antidote Office Locations

Antidote has offices in London, Carmel and New York
London, GB (HQ)
39 Earlham St
Carmel, US
200 S Rangeline Rd
New York, US
450 Park Ave S FL 3
Show all (3)

Antidote Financials and Metrics

Summary Metrics

Founding Date

2009

Antidote total Funding

$17.9 m

Antidote latest funding size

$13.50 m

Time since last funding

5 years ago

Antidote investors

Antidote's latest funding round in February 2015 was reported to be $13.5 m. In total, Antidote has raised $17.9 m
Show all financial metrics

Antidote Revenue

Embed Graph
View revenue for all periods
Antidote's revenue was reported to be £1.51 m in FY, 2018
GBP

Revenue (FY, 2018)

1.5m

Gross profit (FY, 2018)

447.6k

Gross profit margin (FY, 2018), %

29.6%

Net income (FY, 2018)

(5.3m)

EBIT (FY, 2018)

(5.5m)

Cash (31-Dec-2018)

1.0m
GBPFY, 2015FY, 2016FY, 2017FY, 2018

Revenue

2.2m2.4m2.2m1.5m

Revenue growth, %

8%(11%)

Cost of goods sold

912.3k1.1m892.3k1.1m

Gross profit

1.3m1.3m1.3m447.6k
GBPFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

284.3k1.9m147.5k1.3m2.3m6.1m1.0m

Accounts Receivable

73.1k211.4k504.2k647.1k967.5k509.6k268.6k

Inventories

Current Assets

357.4k2.1m651.8k2.2m3.7m7.2m1.8m
GBPFY, 2015FY, 2016FY, 2017

Net Income

(2.2m)(3.3m)(4.6m)
GBPY, 2018

Revenue/Employee

23.0k

Financial Leverage

1.4 x
Show all financial metrics

Antidote Online and Social Media Presence

Embed Graph

Antidote News and Updates

Cash Is The Best COVID-19 Antidote For Mexican Tech Startups

The spread of the coronavirus and its effects on the world economy have dried up funding for cash-hungry Mexican startups, which must now focus on preserving their balance sheets and weathering the storm.

The Toxic Allure Of Fake Emails -- And How To Deploy The Antidote

The war for the corporate email inbox has only just begun.

GM Says Its Battery Is the Android-Style Antidote to Tesla’s iPhone

GM Says Its Battery Is the Android-Style Antidote to Tesla’s iPhone

'Kingdom Hearts III Re: Mind' Is the Antidote to Bad Endings

In a cultural moment where franchises like Star Wars and Game of Thrones don't know how to end well, Kingdom Hearts says: Why end at all?

Windgap Medical and University of Minnesota Twin Cities Receive $3.2 Million NIH Grant to Develop Cyanide Antidote Autoinjector

WATERTOWN, Mass., Jan. 15, 2020 /PRNewswire/ -- Windgap Medical, Inc. and the University of Minnesota Twin Cities have received a $3.2 million grant from the National Institutes of Health (NIH) to develop a new device to quickly administer a recently developed antidote for cyanide...
Show more

Antidote Blogs

Patient engagement during COVID-19 [whitepaper]

Does a health crisis change digital engagement behaviors? How should digital marketers respond?

Inflammatory bowel disease research round-up

Inflammatory bowel disease, commonly referred to as IBD, is an umbrella term used to describe disorders that cause chronic inflammation of the gastrointestinal (GI) tract. The two most common forms of IBD are Crohn’s disease and ulcerative colitis. In 2015, 3 million American adults repo…

The dos and don’ts of social media in clinical trial patient recruitment in 2020

Social media, in its many forms, has become an extremely important component of any clinical trial patient recruitment strategy. At any given time, with 3.5 billion users in the world scrolling through Facebook feeds, creating Instagram stories, and Tweeting out the latest news happening…

Panel recap: “Trial continuity during COVID-19”

COVID-19 is dramatically impacting clinical research, leading to questions about the most effective solutions across the industry. On Thursday, April 16th, ERT hosted an interactive webinar with experts who discussed clinical trial continuity during the COVID-19 pandemic. This “Trial Bet…

PharmaVOICE: "Bringing the Patient Voice into Clinical Trials"

We were honored to be quoted in PharmaVOICE's recent article on how to ensure patient centricity in the clinical trial process, which highlighted the results of our survey of 4,000+ patients and caregivers. 

World Health Day and a celebration of care

Today is World Health Day. The theme this year is celebrating the work of those who care for patients, such as partners, nurses, and midwives. While carers are always critical to the foundations of our healthcare system, it’s particularly important to recognize their essential jobs now, …
Show more

Antidote Frequently Asked Questions

  • When was Antidote founded?

    Antidote was founded in 2009.

  • Who are Antidote key executives?

    Antidote's key executives are Laurent Schockmel, Pablo Graiver and Keith Lovell.

  • How many employees does Antidote have?

    Antidote has 55 employees.

  • What is Antidote revenue?

    Latest Antidote annual revenue is £1.5 m.

  • What is Antidote revenue per employee?

    Latest Antidote revenue per employee is £27.5 k.

  • Who are Antidote competitors?

    Competitors of Antidote include Durect, Amarin and Zogenix.

  • Where is Antidote headquarters?

    Antidote headquarters is located at 39 Earlham St, London.

  • Where are Antidote offices?

    Antidote has offices in London, Carmel and New York.

  • How many offices does Antidote have?

    Antidote has 3 offices.